First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.

Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, ...

Phaze, founded by Parsec's creators, raised an $8.75 million seed round led by a16z to build remote desktops for people and ...

Microsoft says Windows 11 is up to 20% more responsive and 40% faster at multitasking on 8GB RAM PCs. Here's how, and how to ...

ANYbotics, the subject of this article, is a Swiss company that develops industrial facility inspection solutions using the ...

Tutor Intelligence co-founder and CEO Josh Gruenstein argues that robotics is a full-stack systems problem, not an AI-model problem — and that ...

Phaze has raised $8.75 million in seed funding led by a16z to give employees and AI agents access to powerful remote ...

RoboParty RP1 humanoid robot releases SolidWorks CAD, 14 PCB Gerber files, and Isaac Lab training workflows on GitHub -- but ...

Apple's touchscreen MacBook Pro pitches tapping and pinching like they're new, after Apple spent 16 years saying touch didn't ...

Paul Hanaphy is head of content and PR at Artec 3D, a global leader in handheld and portable 3D scanners. Founded in San Diego and with a headquarters in Luxembourg, the company has been at the ...

Mach9, which makes AI CAD software for civil engineering, announced a $34 million Series A on Oct. 21, 2026, co-led by First Round Capital and Bessemer Venture Partners, with Prudence and Quiet ...

First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone.